Pre-Conference Session Information
Legal and Policy Approaches to Reducing Prescription Drug Overdose
Tuesday, May 20, 2014
8:00 AM - 12:00 PM
Hyatt Regency Atlanta
Prescription drug overdose in the United States is at epidemic levels. In this session, participants will learn about this growing problem, and discuss and examine legal and policy options to address it. In particular, the session will focus on two initiatives that have seen rapid uptake in recent years: Prescription Drug Monitoring Program (PDMPs), electronic databases that collect patient-specific prescription information at the point of dispensing and make that information available to authorized entities, and legal changes that increase access to emergency care and treatment for opiate overdose. This category includes laws that make it easier to access to the opioid antagonist naloxone, and legal changes to encourage overdose bystanders to summon first responders. Participants will hear from public health attorneys and practitioners in states that have adopted these initiatives. Through group-based and interactive activities, participants will identify and discuss best practices and appropriate policy options for their state to reduce prescription drug overdose.
Fee: $65 (register for this session through the main meeting registration process
pre-conference session is hosted by the Legal Organizations Consortium with
participation from the CDC National Center for Injury Prevention and Control.
Legal Organizations Consortium (LOC) is a collaboration of ChangeLab Solutions,
the Network for Public Health Law, the Public Health Law Center and Public
Health Law Research. Supported by the CDC’s Office for State, Tribal, Local and
Territorial Support (Cooperative Agreement Number 1U38OT000141-01), the LOC
builds the capacity of the public health workforce to use evidence-based legal
and policy strategies.
Funding for this pre-conference session was made
possible (in part) by the Centers for Disease Control and Prevention. The
views expressed in written conference materials or publications and by speakers
and moderators do not necessarily reflect the official policies of the
Department of Health and Human Services, nor does the mention of trade names,
commercial practices, or organizations imply endorsement by the U.S. Government.